<?xml version='1.0' encoding='utf-8'?>
<document id="25960252"><sentence text="Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization." /><sentence text="Weakly basic compounds which have pH dependent solubility are liable to exhibit pH dependent absorption" /><sentence text=" In some cases, a subtle change in gastric pH can significantly modulate the plasma concentration of the drug and can lead to sub-therapeutic exposure of the drug" /><sentence text=" Evaluating the risk of pH dependent absorption and potential drug-drug interaction with pH modulators are important aspects of drug discovery and development" /><sentence text=" In order to assess the risk around the extent of decrease in the systemic exposure of drugs co-administered with pH modulators in the clinic, a pH effect study is carried out, typically in higher species, mostly dog" /><sentence text=" The major limitation of a higher species pH effect study is the resource and material requirement to assess this risk" /><sentence text=" Hence, these studies are mostly restricted to promising or advanced leads" /><sentence text=" In our current work, we have used in vitro aqueous solubility, in silico simulations using GastroPlusâ„¢ and an in vivo rat pH effect model to provide a qualitative assessment of the pH dependent absorption liability" /><sentence text=" Here, we evaluate ketoconazole and atazanavir with different pH dependent solubility profiles and based on in vitro, in silico and in vivo results, a different extent of gastric pH effect on absorption is predicted"><entity charOffset="19-31" id="DDI-PubMed.25960252.s9.e0" text="ketoconazole" /><entity charOffset="36-46" id="DDI-PubMed.25960252.s9.e1" text="atazanavir" /><pair ddi="false" e1="DDI-PubMed.25960252.s9.e0" e2="DDI-PubMed.25960252.s9.e0" /><pair ddi="false" e1="DDI-PubMed.25960252.s9.e0" e2="DDI-PubMed.25960252.s9.e1" /></sentence><sentence text=" The prediction is in alignment with higher species and human pH effect study results" /><sentence text=" This in vitro, in silico and in vivo (IVISIV) correlation is then extended to assess pH absorption mitigation strategy" /><sentence text=" The IVISIV predicts pH dependent absorption for BMS-582949 whereas its solubility enhancing prodrug, BMS-751324 is predicted to mitigate this liability"><entity charOffset="49-59" id="DDI-PubMed.25960252.s12.e0" text="BMS-582949" /></sentence><sentence text=" Overall, the material requirement for this assessment is substantially low which makes this approach more practical to screen multiple compounds during lead optimization" /><sentence text=" " /></document>